ARGX - ア―ジェンクスSE (argenx SE)

ARGXのニュース

   Argenx stock dips as FDA extends review period for subcutaneous efgartigimod  2023/01/27 10:50:09 Seeking Alpha
Argenx (ARGX) said that the U.S. Food and Drug Administration ((FDA)) extended the review of its application seeking approval of subcutaneous ((SC)) efgartigimod to treat adult…
   argenx: Trigger Ready, But Waiting For Stronger Earnings Profile  2023/01/26 16:00:00 Seeking Alpha
Argenx caught a strong bid in FY22'' on the back of advancements in its Efgartigimod [Vyvgart] pipeline for Myasthenia Gravis. Read more here.
   Argenx reports preliminary FY22 global net sales of Vyvgart  2023/01/09 17:18:29 Seeking Alpha
Argenx (ARGX) said preliminary full-year 2022 global net sales of Vyvgart amounted to $402M.For Q4, preliminary global net sales of Vyvgart (efgartigimod alfa-fcab), which is used to…
   Immunovant Stock: Initiating With A Buy Rating (NASDAQ:IMVT)  2023/01/08 13:47:20 Seeking Alpha
Immunovant is developing a similar drug to argenx, but at 10% of argenx’s valuation. Read more to see the growth catalysts, risks and why I consider it a buy now.
   Morgan Stanley Positive on argenx SE , ''Catalyst Driven Idea: CIDP Topline Readout''  2023/01/05 21:16:02 Investing.com
https://www.investing.com/news/pro/morgan-stanley-positive-on-argenx-se--catalyst-driven-idea-cidp-topline-readout-432SI-2974196
   argenx SE PT Raised to EUR425 at Deutsche Bank  2022/09/22 07:48:10 Investing.com
https://www.investing.com/news/pro/argenx-se-pt-raised-to-eur425-at-deutsche-bank-432SI-2896883
   Argenx files for US approval of subcutaneous form of neuromuscular disorder drug  2022/09/21 09:50:24 Seeking Alpha
Argenx (ARGX) submitted an application to the U.S. Food and Drug Administration ((FDA)) seeking approval of subcutaneous ((SC)) efgartigimod to treat adult patients…
   Should You Consider Investing in Argenx SE (ARGX)?  2022/09/10 03:22:30 Insider Monkey
Baron Funds, an asset management firm, published its “Baron Durable Advantage Fund” second quarter 2022 investor letter – a copy of which can be downloaded here. Baron Durable Advantage Fund (the “Fund”) declined 15.7% (Institutional Shares) during the second quarter, roughly in line with the 16.1% decline for the S&P 500 Index (the “Index”), the […]
   argenx SE PT Raised to $465 at Piper Sandler  2022/08/26 10:43:18 Investing.com
https://www.investing.com/news/pro/argenx-se-pt-raised-to-465-at-piper-sandler-432SI-2880763
   Futures Rise In Morbid Volumes With All Eyes On 50% Fib Retracement Level  2022/08/12 12:08:08 Zero Hedge
Futures Rise In Morbid Volumes With All Eyes On 50% Fib Retracement Level European stocks and US futures rallied on the last day of the week, however traded well off session highs in extremely low-volume trading and tracked the sudden drop in oil, as investors pressed bets that easing inflation will allow the Fed to pivot to less aggressive rate hiking (if not ease outright). S&P 500 and Nasdaq 100 contracts rose about 0.3%, with both underlying indexes set to post their longest sequence of weekly gains since November. Treasury yields were steady at 2.87% and the US dollar rose but was set for the worst week since May. Crude oil fell, reducing its biggest weekly gain in about four months. Gold headed for a fourth weekly gain and Bitcoin was summarily smacked down below the $24,000 level yet again as crypto bears fight to preserve the upper hand. For the second day in a row an attempt to void the bear market rally narrative by pushing spoos above the 50% fib retracement level is being defended by bears, with futures trading at 4222, or right on top of the critical level, which also doubles as the 100DMA.
   argenx SE PT Raised to EUR425 at Deutsche Bank  2022/09/22 07:48:10 Investing.com
https://www.investing.com/news/pro/argenx-se-pt-raised-to-eur425-at-deutsche-bank-432SI-2896883
   Argenx files for US approval of subcutaneous form of neuromuscular disorder drug  2022/09/21 09:50:24 Seeking Alpha
Argenx (ARGX) submitted an application to the U.S. Food and Drug Administration ((FDA)) seeking approval of subcutaneous ((SC)) efgartigimod to treat adult patients…
   Should You Consider Investing in Argenx SE (ARGX)?  2022/09/10 03:22:30 Insider Monkey
Baron Funds, an asset management firm, published its “Baron Durable Advantage Fund” second quarter 2022 investor letter – a copy of which can be downloaded here. Baron Durable Advantage Fund (the “Fund”) declined 15.7% (Institutional Shares) during the second quarter, roughly in line with the 16.1% decline for the S&P 500 Index (the “Index”), the […]
   argenx SE PT Raised to $465 at Piper Sandler  2022/08/26 10:43:18 Investing.com
https://www.investing.com/news/pro/argenx-se-pt-raised-to-465-at-piper-sandler-432SI-2880763
   Futures Rise In Morbid Volumes With All Eyes On 50% Fib Retracement Level  2022/08/12 12:08:08 Zero Hedge
Futures Rise In Morbid Volumes With All Eyes On 50% Fib Retracement Level European stocks and US futures rallied on the last day of the week, however traded well off session highs in extremely low-volume trading and tracked the sudden drop in oil, as investors pressed bets that easing inflation will allow the Fed to pivot to less aggressive rate hiking (if not ease outright). S&P 500 and Nasdaq 100 contracts rose about 0.3%, with both underlying indexes set to post their longest sequence of weekly gains since November. Treasury yields were steady at 2.87% and the US dollar rose but was set for the worst week since May. Crude oil fell, reducing its biggest weekly gain in about four months. Gold headed for a fourth weekly gain and Bitcoin was summarily smacked down below the $24,000 level yet again as crypto bears fight to preserve the upper hand. For the second day in a row an attempt to void the bear market rally narrative by pushing spoos above the 50% fib retracement level is being defended by bears, with futures trading at 4222, or right on top of the critical level, which also doubles as the 100DMA.

calendar